Bioventix (FRA:51B) Valuation Rank


FRA:51B Bioventix PLC FRA:51B
64 GF Score
Price €17.50
GF Value €38.68
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Bioventix Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Bioventix Valuation Rank Related Terms

FRA:51B
64GF Score
Bioventix PLC FRA:51B
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bioventix (FRA:51B) Overvalued in 2026?

Based on GuruFocus' analysis, Bioventix stock appears to be undervalued. The current stock price of €17.50 is trading 54.8% below its estimated GF Value™ of €38.68. GuruFocus considers Bioventix to be Significantly Undervalued.

Key valuation signals for FRA:51B:

  • Valuation Rank:
  • GF Value™: €38.68 vs. price of €17.50 (54.8% below fair value)
  • GF Score™: 64/100 with 3 warning signs

No single metric tells the full story. See the FRA:51B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bioventix Business Description

Other Exchanges BVXP:UK
Address 27-28 Eastcastle Street, London, GBR, W1W 8DH
Bioventix PLC is a biotechnology company based in the United Kingdom. It specializes in the creation and supply of high-affinity sheep monoclonal antibodies and clinical diagnostics and drug abuse testing. The company's portfolio of products includes drugs that are applicable in the areas of cardiology, fertility, infectious diseases, Thyroid, and vitamin D disorder among others. It earns maximum revenue from European country.
64GF Score

Get the complete analysis for FRA:51B

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€17.50
Price
€38.68
GF Value